Nishadil
Signup Signin
Delhi | 25°C (windy)
Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market

Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market
The Price Tag Blues: Unpacking Novo Nordisk's Bold Move on Ozempic and Wegovy for Self-Pay Patients

The Price Tag Blues: Unpacking Novo Nordisk's Bold Move on Ozempic and Wegovy for Self-Pay Patients
The Great Weight Debate: Unpacking the White House's Bold Move on Obesity Drugs

The Great Weight Debate: Unpacking the White House's Bold Move on Obesity Drugs
The GLP-1 Drug Dilemma: Insurers Battle Costs While Patients Face Uncertain Future

The GLP-1 Drug Dilemma: Insurers Battle Costs While Patients Face Uncertain Future
The Unbearable Weight of Price Tags: Why Life-Changing Weight Loss Drugs Remain Out of Reach

The Unbearable Weight of Price Tags: Why Life-Changing Weight Loss Drugs Remain Out of Reach
Life-Saving Cancer Drugs Out of Reach: India's Price Control Gap Leaves Patients Vulnerable

Life-Saving Cancer Drugs Out of Reach: India's Price Control Gap Leaves Patients Vulnerable
Load more..